Matches in SemOpenAlex for { <https://semopenalex.org/work/W2492705434> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2492705434 abstract "Our recent work suggested that inhibition of mTORC1 activates Mnk in a PI3K-dependent manner, thereby providing a survival mechanism for medulloblastoma cells. The PI3K-Akt axis represents an important survival pathway that also confers therapy resistance to medulloblastoma stem cells, resulting in tumor recurrence. Here, we investigated a role for p110 isoforms of PI3K in medulloblastoma stem-like cancer cell biology and studied the potential of Mnk inhibition for sensitizing medulloblastoma stem-like cancer cells and orthotopic xenograft tumors to PI3K inhibition. We used medulloblastoma cell lines Daoy and D556 grown as conventional 2-D cultures or under stem-cell conditions as 3-D neurospheres to elucidate the roles of PI3K-Akt signaling in medulloblastoma proliferation, colony formation and stem cell function. We employed extreme limiting dilution analysis (ELDA) to ask whether concomitant Mnk inhibition enhances antineoplastic effects of PI3K inhibition on cancer stem cell growth. Additionally, in a preliminary intracereballar xenograft mouse study, we investigated the effects of pharmacologic PI3K and Mnk inhibition. We found that Akt activity greatly increased when 2-D cultures were converted into 3-D neurospheres. This Akt activation coincided with increased expression of CD133 and nestin, suggesting an important role for PI3K-Akt signaling in medulloblastoma stem cells. The p110a specific inhibitor BYL-719 blocked this Akt activation in neurospheres indicating this Akt activation is mediated by p110a. Consistently, of all class I PI3K catalytic isoforms (p110a, p110b, p110d and p110g) only knockdown of p110a disrupted stem cell frequencies in ELDA. We previously reported that mTORC1 inhibition engages Mnk signaling in a negative feedback manner to promote survival. Here we show that Mnk inhibition by CGP57380 sensitized medulloblastoma cells for pharmacologic inhibition and siRNA-mediated knockdown of p110a both in 2-D cancer cells and 3-D stem-like cancer cell cultures. After intracerebellar injection of medulloblastoma cells in nude mice, we found that combined targeting of PI3K-p110a and Mnk results in inhibition of tumor growth and increased survival. In summary, pharmacologic inhibition of PI3K-p110a by BYL-719 showed potent activity against medulloblastoma cells and stem-like cancer cells. Knockdown of p110a disrupted cancer stem cell frequency in ELDA and this effect was greatly enhanced by pharmacologic inhibition of Mnk. Finally, in an orthotopic mouse model we found that concomitant inhibition of p110a and Mnk prolonged survival and reduced tumor size. The striking effects of concomitant Mnk inhibition on stem-like cancer cells, neurospheres and tumors is particularly interesting as it suggests enhanced vulnerability of the therapy-resistant, tumor-initiating cancer stem cell population to p110a inhibition in medulloblastoma. Citation Format: Jonathan B. Bell, Frank Eckerdt, Quanhong Ma, Jessica R. Clymer, Stewart Goldman, Rintaro Hashizume, Leonidas C. Platanias. Mnk targeting enhances vulnerability of medulloblastoma stem-like cancer cells to PI3K-p110alpha inhibition. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr LB-009." @default.
- W2492705434 created "2016-08-23" @default.
- W2492705434 creator A5008404018 @default.
- W2492705434 creator A5037070644 @default.
- W2492705434 creator A5039821839 @default.
- W2492705434 creator A5051335860 @default.
- W2492705434 creator A5052155954 @default.
- W2492705434 creator A5071378074 @default.
- W2492705434 creator A5078403556 @default.
- W2492705434 date "2016-07-15" @default.
- W2492705434 modified "2023-09-27" @default.
- W2492705434 title "Abstract LB-009: Mnk targeting enhances vulnerability of medulloblastoma stem-like cancer cells to PI3K-p110alpha inhibition" @default.
- W2492705434 doi "https://doi.org/10.1158/1538-7445.am2016-lb-009" @default.
- W2492705434 hasPublicationYear "2016" @default.
- W2492705434 type Work @default.
- W2492705434 sameAs 2492705434 @default.
- W2492705434 citedByCount "0" @default.
- W2492705434 crossrefType "proceedings-article" @default.
- W2492705434 hasAuthorship W2492705434A5008404018 @default.
- W2492705434 hasAuthorship W2492705434A5037070644 @default.
- W2492705434 hasAuthorship W2492705434A5039821839 @default.
- W2492705434 hasAuthorship W2492705434A5051335860 @default.
- W2492705434 hasAuthorship W2492705434A5052155954 @default.
- W2492705434 hasAuthorship W2492705434A5071378074 @default.
- W2492705434 hasAuthorship W2492705434A5078403556 @default.
- W2492705434 hasConcept C104317684 @default.
- W2492705434 hasConcept C148738053 @default.
- W2492705434 hasConcept C162746124 @default.
- W2492705434 hasConcept C20875687 @default.
- W2492705434 hasConcept C2780789225 @default.
- W2492705434 hasConcept C28328180 @default.
- W2492705434 hasConcept C502942594 @default.
- W2492705434 hasConcept C54355233 @default.
- W2492705434 hasConcept C55427017 @default.
- W2492705434 hasConcept C62478195 @default.
- W2492705434 hasConcept C75217442 @default.
- W2492705434 hasConcept C86554907 @default.
- W2492705434 hasConcept C86803240 @default.
- W2492705434 hasConcept C95444343 @default.
- W2492705434 hasConcept C98490376 @default.
- W2492705434 hasConceptScore W2492705434C104317684 @default.
- W2492705434 hasConceptScore W2492705434C148738053 @default.
- W2492705434 hasConceptScore W2492705434C162746124 @default.
- W2492705434 hasConceptScore W2492705434C20875687 @default.
- W2492705434 hasConceptScore W2492705434C2780789225 @default.
- W2492705434 hasConceptScore W2492705434C28328180 @default.
- W2492705434 hasConceptScore W2492705434C502942594 @default.
- W2492705434 hasConceptScore W2492705434C54355233 @default.
- W2492705434 hasConceptScore W2492705434C55427017 @default.
- W2492705434 hasConceptScore W2492705434C62478195 @default.
- W2492705434 hasConceptScore W2492705434C75217442 @default.
- W2492705434 hasConceptScore W2492705434C86554907 @default.
- W2492705434 hasConceptScore W2492705434C86803240 @default.
- W2492705434 hasConceptScore W2492705434C95444343 @default.
- W2492705434 hasConceptScore W2492705434C98490376 @default.
- W2492705434 hasLocation W24927054341 @default.
- W2492705434 hasOpenAccess W2492705434 @default.
- W2492705434 hasPrimaryLocation W24927054341 @default.
- W2492705434 hasRelatedWork W1491234261 @default.
- W2492705434 hasRelatedWork W1548830643 @default.
- W2492705434 hasRelatedWork W1607900767 @default.
- W2492705434 hasRelatedWork W1764369885 @default.
- W2492705434 hasRelatedWork W1973011428 @default.
- W2492705434 hasRelatedWork W1983710920 @default.
- W2492705434 hasRelatedWork W2008170212 @default.
- W2492705434 hasRelatedWork W2014865890 @default.
- W2492705434 hasRelatedWork W2046635534 @default.
- W2492705434 hasRelatedWork W2063195293 @default.
- W2492705434 hasRelatedWork W2078094439 @default.
- W2492705434 hasRelatedWork W2326314510 @default.
- W2492705434 hasRelatedWork W2332585649 @default.
- W2492705434 hasRelatedWork W2501533452 @default.
- W2492705434 hasRelatedWork W2542343181 @default.
- W2492705434 hasRelatedWork W2740409646 @default.
- W2492705434 hasRelatedWork W2885553023 @default.
- W2492705434 hasRelatedWork W2953427566 @default.
- W2492705434 hasRelatedWork W2980257051 @default.
- W2492705434 hasRelatedWork W3214497511 @default.
- W2492705434 isParatext "false" @default.
- W2492705434 isRetracted "false" @default.
- W2492705434 magId "2492705434" @default.
- W2492705434 workType "article" @default.